SILEXION THERAPEUTICS CORP
Q1 2025 13F Holders
Symbol
SLXN
CUSIP
G1281K122
Type
Equity
Class
SHS NEW
Num filings
6
Total reported value, excl. options
$260 k
Compare 2025 Q1 to
2025 Q2
2024 Q4
Manager
Report Date
Value ($000)
Shares
Option Type